For: | Zhang HQ, Li J, Tan CL, Chen YH, Zheng ZJ, Liu XB. Neoadjuvant therapy in resectable pancreatic cancer: A promising curative method to improve prognosis. World J Gastrointest Oncol 2022; 14(10): 1903-1917 [PMID: 36310705 DOI: 10.4251/wjgo.v14.i10.1903] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v14/i10/1903.htm |
Number | Citing Articles |
1 |
Sung Woo Ko, Seung Bae Yoon. Clinical implications and perspectives of portal venous circulating tumor cells in pancreatic cancer. World Journal of Gastrointestinal Oncology 2023; 15(4): 632-643 doi: 10.4251/wjgo.v15.i4.632
|
2 |
Qingquan Tan, Chen Chen, Ziyao Wang, Haoqi Zhang, Xubao Liu, Nengwen Ke. Prognostic role of radiological splenic vessel involvement in patients with resectable pancreatic ductal adenocarcinoma of the body and tail: A retrospective analysis based on a large population. European Journal of Radiology 2023; 165: 110952 doi: 10.1016/j.ejrad.2023.110952
|
3 |
Lauren M. Janczewski, Joanna Buchheit, Ryan C. Jacobs, Dominic Vitello, Amy Wells, John Abad, David J. Bentrem, Akhil Chawla. Utilization and survival outcomes of neoadjuvant chemotherapy for early‐stage gastric cancer. Journal of Surgical Oncology 2024; 130(2): 249 doi: 10.1002/jso.27732
|
4 |
Shruti Koti, Oliver Standring, Nandan Vithlani, Neda Amini, Danielle Deperalta, Gary Deutsch, Martin Karpeh, Matthew Weiss, Neha Lad. Trends and Outcomes of Neoadjuvant Chemotherapy for Clinical Stage T1 Pancreatic Cancer. Journal of Surgical Oncology 2024; doi: 10.1002/jso.28003
|
5 |
Chun-Ye Zhang, Shuai Liu, Ming Yang. Clinical diagnosis and management of pancreatic cancer: Markers, molecular mechanisms, and treatment options. World Journal of Gastroenterology 2022; 28(48): 6827-6845 doi: 10.3748/wjg.v28.i48.6827
|
6 |
Seung Bae Yoon, Sung Woo Ko. Clinical Utility of Portal Venous Circulating Tumor Cells in Pancreatic Cancer. Journal of Digestive Cancer Research 2023; 11(1): 21 doi: 10.52927/jdcr.2023.11.1.21
|